RRC ID 37586
Author Osaki T, Yokoe I, Uto Y, Ishizuka M, Tanaka T, Yamanaka N, Kurahashi T, Azuma K, Murahata Y, Tsuka T, Ito N, Imagawa T, Okamoto Y.
Title Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate.
Journal Ultrason Sonochem
Abstract Sonodynamic therapy (SDT), or ultrasound combined with sonosensitization, is a promising approach because it is noninvasive and penetrates deeper than light does in photodynamic therapy. We examined whether bleomycin (BLM) could improve the efficacy of SDT. We performed an in vitro study using Colon-26 cells, which are derived from mouse colon cancer. SDT with BLM was significantly more cytotoxic than SDT alone both in vitro and in vivo. We also observed an ultrasound intensity-dependent cytotoxic effect of SDT with BLM. These findings suggest that SDT with BLM might provide a novel noninvasive treatment for deep-seated tumors.
Volume 28
Pages 161-168
Published 2016-1-1
DOI 10.1016/j.ultsonch.2015.07.013
PII S1350-4177(15)00227-8
PMID 26384895
MeSH Animals Bleomycin / pharmacology* Caspase 3 / metabolism Caspase 7 / metabolism Cell Line, Tumor Dose-Response Relationship, Drug Drug Synergism Indoles / pharmacology* Mice Organometallic Compounds / pharmacology* Time Factors Ultrasonic Waves*
IF 6.513
Times Cited 13
WOS Category ACOUSTICS CHEMISTRY, MULTIDISCIPLINARY
Resource
Human and Animal Cells Colon-26(RCB2657)